Abaxx Technologies Appoints Leah Wald as Commercial Advisor Appointment supports commercial readiness of Abaxx Digital Title platform ahead of multi-market pilot program GlobeNewswire October 23, 2025 TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX) (“Abaxx” or the “Company“), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., […]
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=173577&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your LifeMD, Inc. (NASDAQ:LFMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=173576&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=173575&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
Suburban Propane Partners, L.P. (NYSE: SPH), today announced that its Board of Supervisors declared a quarterly distribution of $0.325 per Common Unit for the three months ended September 27, 2025. This quarterly distribution rate equates to an annualized rate of $1.30 per Common Unit. The distribution is payable on November 11, 2025 to Common Unitholders
Prescription medications were found to be a key driver of Medicare expendituresand patient liability For individuals enrolled in Medicare, medical expenses in the first year following an ALS diagnosis top $47,000-more than three times higher than the average Medicare beneficiary, according to a new study led by the ALS Association. https://mma.prnewswire.com/media/541127/ALS_Logo.jpg The findings, which were
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=173585&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=173583&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=173574&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your Semler Scientific, Inc. (NASDAQ:SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=173584&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or